PanOmiQ Set’s New Benchmark with 100% Accuracy in Whole Genome Sequencing Testing.pdf

CALGARY, Alberta, Aug. 20, 2024 (GLOBE NEWSWIRE) -- BioAro, a leading precision health and genomics company, is proud to announce a groundbreaking achievement in the field of Whole Genome Sequencing (WGS). Using the cutting-edge AI-powered PanOmiQ platform, BioAro’s laboratory has successfully processed a WGS sample provided by the College of American Pathologists (CAP) and received a 100% match in variant calling (identifying genetic differences) - an accomplishment that is difficult in genomic science.

1. PanOmiQ Set’s New Benchmark
with 100% Accuracy in Whole
Genome Sequencing Testing
bioaro.com

2. bioaro.com
CALGARY, Alberta, Aug. 20, 2024 (GLOBE NEWSWIRE) -- BioAro, a
leading precision health and genomics company, is proud to
announce a groundbreaking achievement in the field of Whole
Genome Sequencing (WGS). Using the cutting-edge AI-powered
PanOmiQ platform, BioAro’s laboratory has successfully processed
a WGS sample provided by the College of American Pathologists
(CAP) and received a 100% match in variant calling (identifying
genetic differences) - an accomplishment that is difficult in
genomic science.

3. bioaro.com
Whole Genome Sequencing is a powerful tool in precision medicine,
but the complexity of the human genome and differences in
sequencing technologies and bioinformatics pipelines make
achieving a 100% match in variant calls between laboratories
extremely difficult. . BioAro's achievement is a significant milestone
in overcoming these challenges.
This breakthrough was made possible by leveraging the PanOmiQ
platform, a revolutionary technology that integrates advanced
machine learning algorithms, real-time data sharing, and
standardized bioinformatics pipelines to deliver unparalleled
accuracy in genomic analysis. PanOmiQ’s ability to standardize
processes across different labs ensures consistency and reliability
in variant calling, a crucial factor in achieving the rare 100% match.

4. bioaro.com

5. bioaro.com
Dr. Minal Tripathi, Director of Genomics at BioAro, commented, "This
accomplishment is a testament to the power of innovation and
collaboration. PanOmiQ has enabled us to transcend the
conventional challenges in variant calling, delivering a level of
accuracy once considered formidable to attain.
“The probability of achieving a 100% match in variant calls
between two independent labs is extraordinarily low due to the
inherent complexities of the human genome and the variability in
sequencing technologies. However, with PanOmiQ, we have
demonstrated that it is possible to achieve this level of precision,
opening new doors for the future of genomics and personalized
healthcare,” shared Dr. Divya Mishra, Lead Genomics Scientist at
BioAro.

6. bioaro.com

7. bioaro.com
Mr. Sidharth S. Bhinder, Chief Technology Officer at BioAro, adds:
“Achieving a perfect match in WGS transforms precision medicine,
allowing for more accurate diagnoses and personalized treatment
plans. This breakthrough reaffirms our commitment to advancing
healthcare through innovative technology.”
Dr. Anmol Kapoor, Founder and CEO of BioAro, shared his vision for
the future: “This milestone represents a major leap forward in our
mission to deliver the most accurate and reliable genomic data to
clinicians and researchers. PanOmiQ’s AI-driven approach has set
a new standard in the industry, and we are excited to continue
pushing the boundaries of what is possible in precision medicine.
BioAro is committed to using this technology to improve patient
outcomes and advance our understanding of the human
genome.”

8. bioaro.com
The successful 100% matching of variants underscores BioAro’s
commitment to excellence in genomic research and its dedication
to leveraging the latest technologies to enhance precision
medicine. This achievement not only demonstrates the capabilities
of PanOmiQ but also sets a new benchmark for the entire genomics
industry.
For more information about BioAro and its recent breakthrough,
please visit www.BioAro.com. To book a demo of PanOmiQ, visit
www.PanOmiQ.com.

9. bioaro.com
About BioAro
BioAro is a pioneering Precision Health and genomics company
based in Calgary, Alberta. Focused on advancing personalized
medicine through cutting-edge genomic technologies, BioAro
offers a range of services, including Whole Genome Sequencing,
Whole Exome Sequencing, Genetic Testing, Shotgun
Metagenomics, Microbiome Testing and Bioinformatics analysis.
The company is dedicated to improving patient outcomes by
delivering accurate, actionable insights into the human genome.